Medical Journals

Trpc3/C7 and Slo2.1 Are Molecular Targets for Metabotropic Glutamate Receptor Signaling in Rat Striatal Cholinergic Interneurons.

Authors:
  • Berg Allison P
  • Sen Neil
  • Bayliss Douglas A

From: Department of Pharmacology, University of Virginia, Charlottesville, Virginia 22908, USA. a-berg@northwestern.edu

The Journal of neuroscience : the official journal of the Society for Neuroscience

  • Publish Date: Aug 2007
  • ISSN: 1529-2401
  • Volume: 27
  • Issue: 33
  • Pages: 8845-56
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Berg Allison P, Sen Neil, Bayliss Douglas A, et al. Trpc3/C7 and Slo2.1 Are Molecular Targets for Metabotropic Glutamate Receptor Signaling in Rat Striatal Cholinergic Interneurons.. J. Neurosci. Aug 2007;27:8845-56

Abstract

Large aspiny cholinergic interneurons provide the sole source of striatal acetylcholine, a neurotransmitter critical for basal ganglia function; these tonically active interneurons receive excitatory inputs from corticostriatal glutamatergic afferents that act, in part, via metabotropic glutamate receptors (mGluRs). We combined electrophysiological recordings in brain slices with molecular neuroanatomy to identify distinct ion channel targets for mGluR1/5 receptors in striatal cholinergic interneurons: transient receptor potential channel 3/7 (TrpC3/C7) and Slo2.1. In recordings obtained with methanesulfonate-based internal solutions, we found an mGluR-activated current with voltage-dependent and pharmacological properties reminiscent of TrpC3 and TrpC7; expression of these TrpC subunits in cholinergic interneurons was verified by combined immunohistochemistry and in situ hybridization, and modulation of both TrpC channels was reconstituted in HEK293 (human embryonic kidney 293) cells cotransfected with mGluR1 or mGluR5. With a chloride-based internal solution, mGluR agonists did not activate interneuron TrpC-like currents. Instead, a time-dependent, outwardly rectifying K(+) current developed after whole-cell access, and this Cl(-)-activated K(+) current was strongly inhibited by volatile anesthetics and mGluR activation. This modulation was recapitulated in cells transfected with Slo2.1, a Na(+)- and Cl(-)-activated K(+) channel, and Slo2.1 expression was confirmed histochemically in striatal cholinergic interneurons. By using gramicidin perforated-patch recordings, we established that the predominant agonist-activated current was TrpC-like when ambient intracellular chloride was preserved, although a small K(+) current contribution was observed in some cells. Together, our data indicate that mGluR1/5-mediated glutamatergic excitation of cholinergic interneurons is primarily a result of activation of TrpC3/TrpC7-like cationic channels; under conditions when intracellular NaCl is elevated, a Slo2.1 background K(+) channel may also contribute.

Mesh Headings (Keywords): Acetylcholine, Analysis of Variance, Animals, Animals, Newborn, Cell Line, Transformed, Corpus Striatum, Dose-Response Relationship, Radiation, Electric Stimulation, Excitatory Amino Acid Agents, Gene Expression Regulation, Glycine, Humans, Interneurons, Membrane Potentials, Patch-Clamp Techniques, Potassium Channels, Potassium Chloride, Rats, Rats, Sprague-Dawley, Receptors, Metabotropic Glutamate, Resorcinols, Signal Transduction, TRPC Cation Channels, Transfection


Check for Full Text / PubMed Unique Identifier (PMID): 17699666


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.